Price T Rowe Associates Inc Immunic, Inc. Transaction History

Price T Rowe Associates Inc

  • $867 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$11.76 - $16.85 $3.09 Million - $4.42 Million
-262,382 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$14.21 - $25.3 $2.16 Million - $3.85 Million
-152,097 Reduced 36.7%
262,382 $4.18 Million
Q4 2020

Feb 16, 2021
BUY
$14.8 - $20.37 $6.13 Million - $8.44 Million
414,479 New
414,479 $6.34 Million

Others Institutions Holding IMUX

# of Institutions
75
Shares Held
51.2M
Call Options Held
824K
Put Options Held
354K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $32.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email